Mind over sickle cell: can stress relief ease the pain?
NCT ID NCT07316478
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a stress management and mindfulness program can improve quality of life for adults with sickle cell disease. The program includes techniques from cognitive-behavioral therapy, relaxation exercises, and mindfulness meditation. Researchers will enroll 50 participants who live within 90 minutes of Philadelphia to see if the program helps with pain, mood, and daily function.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Stress management and mindfulness program (behavioral intervention)
- What this could lead to
- If it works, this could offer a low-risk way to help people with sickle cell disease feel better day-to-day and manage stress.
- What could go wrong
- This is a small, early-stage trial with only 50 people, so results may not apply to everyone. The program is behavioral, not a medical treatment, so it won't cure the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Co-Designed support help parents embrace sickle cell care?
- Can community hospitals in zambia master severe disease care?
- A Pocket-Sized coach for sickle cell: can an app turn Pill-Taking into a habit?
- Can a phone app keep teens on track with sickle cell treatment?
- A common amino acid may calm sickle cell pain crises — a trial puts it to the test
- A drug that protects the liver may make stem cell transplants safer for children with sickle cell disease